Corvus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Samlyn Capital, LLC(9.99%),Samlyn, LP(9.99%)等
Corvus Pharmaceuticals | 4:持股变动声明-董事 Grais Linda
Corvus Pharmaceuticals | 4:持股变动声明-董事 CLARK IAN T
Corvus Pharmaceuticals | 4:持股变动声明-董事 Gould Terry P
Corvus Pharmaceuticals | 4:持股变动声明-董事 Morrison Scott W
Corvus Pharmaceuticals | 4:持股变动声明-董事 Thompson Peter A.
Corvus Pharmaceuticals | 4:持股变动声明-高管 MILLER RICHARD A MD
Corvus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Samlyn Capital, LLC(9.99%),Samlyn, LP(9.99%)等
Corvus Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Point72 Asset Management, L.P.(9.9%),Point72 Capital Advisors, Inc.(9.9%)等
Corvus Pharmaceuticals | 4:持股变动声明-董事 Thompson Peter A.
Corvus Pharmaceuticals | 4:持股变动声明-董事 ORBIMED ADVISORS LLC
Corvus Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-OrbiMed Advisors LLC(11.1%),OrbiMed Capital GP V LLC(11.1%)
Corvus Pharmaceuticals | 4:持股变动声明-高管 Jones William Benton
Corvus Pharmaceuticals | 4:持股变动声明-高管 MILLER RICHARD A MD
Corvus Pharmaceuticals | 4:持股变动声明-高管 Arcara Jeffrey
Corvus Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Samlyn Capital, LLC(5.1%),Samlyn, LP(5.1%)等
Corvus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Richard A. Miller(7.19%),Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985(3.04%)等
Corvus Pharmaceuticals | 3:首次持股声明-高管 Arcara Jeffrey
Corvus Pharmaceuticals | 4:持股变动声明-高管 MILLER RICHARD A MD
Corvus Pharmaceuticals | 4:持股变动声明-首席财务官 LEA LEIV
暂无数据
暂无数据